As we age, our vision changes and because of this it can be more susceptible for developing age-related eye conditions. However people shouldn’t assume that they will eventually lose their eyesight as a result; most times these problems are preventable or treatable rather then inevitable like some might think. Healthy aging should be a priority […]
Author: Global Health Europe
Miltefosine is an oral anti-infective that has been used to treat several forms of leishmaniasis, including cutaneous and visceral. Post-Kala Azar Dermal Leishmanias (PKDL) commonly occurs 6 months – 1 year after apparent cure in VL patients; however it can also occur as a sequela for people who were given treatment later on during their […]
As of Monday 31 January, the European Union (EU) will be implementing a new Clinical Trials Information System (CTIS) that is designed to improve trial conducting and participant safety. This event marks one step closer for harmonizing rules across member states in order to make life easier on researchers as well as those who may […]
Anti-smoking legislation has led to a demonstrable reduction in the number of children being admitted to hospital with respiratory tract infections. This was shown in a study conducted by Jasper Been, paediatrician at Maastricht UMC+. The researcher, who also works at Edinburgh University and Erasmus MC, examined how anti-smoking legislation has affected child health in […]
All light is not equal: blue wavelengths are the most potent portion of the visible electromagnetic spectrum for circadian regulation. Therefore, blocking blue light could create a form of physiologic darkness. Because the timing and quantity of light and darkness both affect sleep, evening use of amber lenses to block blue light might affect sleep […]
After losing money with the shares of a particular company, individual investors are unlikely to buy that particular product or service again. Although investment results appear to have little to do with how satisfied a customer is with a company’s product, stock market losses do tend to diminish customer satisfaction and customer loyalty in the […]
Categories
Germany launches its global health strategy
On July 10th, 2013 the German government launched its global health strategy entitled “Globale Gesundheitspolitik gestalten – Gemeinsam handeln – Verantwortung wahrnehmen” (Global Health Policy – Acting Together – recognizing responsibility). The goal of this concept is to make an active and consolidated contribution to solving the global health challenges of our time. As such […]
Michelle Gagnon and Ronald Labonté recently published an interesting article on how and why health is integrated into foreign policy. They did so by appraising the UK Global Health Strategy 2008-2013 through in-depth document analysis and 20 interviews with key stake holders. Their findings provide great insight into the reasons for why the British governments […]
WHO’s Health Assembly, the world’s largest health policy-making body opened its 66th Session in Geneva with around 3000 participants from around the world. Major health issues to be discussed include: preventing and controlling noncommunicable diseases such as diabetes, heart disease, cancers and chronic lung disease; monitoring of progress countries are making towards the Millennium Development […]
The following text is an excerpt from a background note entitled: Globalisation, EU policies and the impact on the Dutch Health System, written by Remco van de Pas, global health advocate from Stichting Wemos, The Netherlands. The background document was used to inform a debate on 09 April on globalisation and the Dutch health system, […]